GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Zhongyuan Union Cell & Gene Engineering Corp Ltd (SHSE:600645) » Definitions » Operating Margin %

Zhongyuan Union Cell & Gene Engineering (SHSE:600645) Operating Margin % : 10.46% (As of Mar. 2025)


View and export this data going back to 1993. Start your Free Trial

What is Zhongyuan Union Cell & Gene Engineering Operating Margin %?

Operating Margin % is calculated as Operating Income divided by its Revenue. Zhongyuan Union Cell & Gene Engineering's Operating Income for the three months ended in Mar. 2025 was ¥37 Mil. Zhongyuan Union Cell & Gene Engineering's Revenue for the three months ended in Mar. 2025 was ¥351 Mil. Therefore, Zhongyuan Union Cell & Gene Engineering's Operating Margin % for the quarter that ended in Mar. 2025 was 10.46%.

The historical rank and industry rank for Zhongyuan Union Cell & Gene Engineering's Operating Margin % or its related term are showing as below:

SHSE:600645' s Operating Margin % Range Over the Past 10 Years
Min: 8.22   Med: 11.89   Max: 15.4
Current: 11.85


SHSE:600645's Operating Margin % is ranked better than
83.27% of 992 companies
in the Biotechnology industry
Industry Median: -126.37 vs SHSE:600645: 11.85

Zhongyuan Union Cell & Gene Engineering's 5-Year Average Operating Margin % Growth Rate was -0.30% per year.

Zhongyuan Union Cell & Gene Engineering's Operating Income for the three months ended in Mar. 2025 was ¥37 Mil. Its Operating Income for the trailing twelve months (TTM) ended in Mar. 2025 was ¥182 Mil.


Zhongyuan Union Cell & Gene Engineering Operating Margin % Historical Data

The historical data trend for Zhongyuan Union Cell & Gene Engineering's Operating Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Zhongyuan Union Cell & Gene Engineering Operating Margin % Chart

Zhongyuan Union Cell & Gene Engineering Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Operating Margin %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 9.29 12.46 10.92 11.32 12.84

Zhongyuan Union Cell & Gene Engineering Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Operating Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 14.57 14.32 16.13 5.96 10.46

Competitive Comparison of Zhongyuan Union Cell & Gene Engineering's Operating Margin %

For the Biotechnology subindustry, Zhongyuan Union Cell & Gene Engineering's Operating Margin %, along with its competitors' market caps and Operating Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Zhongyuan Union Cell & Gene Engineering's Operating Margin % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Zhongyuan Union Cell & Gene Engineering's Operating Margin % distribution charts can be found below:

* The bar in red indicates where Zhongyuan Union Cell & Gene Engineering's Operating Margin % falls into.


;
;

Zhongyuan Union Cell & Gene Engineering Operating Margin % Calculation

Operating Margin % - also known as operating income margin, operating profit margin and return on sales (ROS) - is the ratio of Operating Income divided by net sales or Revenue, usually presented in percent.

Zhongyuan Union Cell & Gene Engineering's Operating Margin % for the fiscal year that ended in Dec. 2024 is calculated as

Operating Margin %=Operating Income (A: Dec. 2024 ) / Revenue (A: Dec. 2024 )
=203.571 / 1585.423
=12.84 %

Zhongyuan Union Cell & Gene Engineering's Operating Margin % for the quarter that ended in Mar. 2025 is calculated as

Operating Margin %=Operating Income (Q: Mar. 2025 ) / Revenue (Q: Mar. 2025 )
=36.697 / 350.79
=10.46 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Zhongyuan Union Cell & Gene Engineering  (SHSE:600645) Operating Margin % Explanation

Just like Gross Margin %, it is important to see a company maintains its operating margin over time. Among the same industry, a company with higher operating margin is more efficient in its operation. It is also more stable during industry slowdown or recessions. Peter Lynch prefers those with higher margins than those with lower margins.


Be Aware

Operating Margin % can be manipulated by adjusting the rate of depreciation, depletion and amortization (DDA).

If a company is facing competition, its Operating Margin % may decline. Often the Operating Margin % declines well before the company's Revenue or even profit decline. Therefore, Operating Margin % is a very important indicator of whether the company is facing problems.

For instance, by 2012, Nokia (NOK)'s problems were well known and its stock had lost more than 90% of its market value since 2007. But Nokia’s Operating Margin % had already been in decline since 2002, although its Earnings per Share (Diluted) were still rising. Investors who paid attention to Operating Margin % would have avoided this huge loss. The same can be said for Research-in-Motion (RIMM).

Therefore, Operating Margin % is a very important screening filter for GuruFocus. GuruFocus's Buffett-Munger screener requires that the profit margin is either consistent or expanding. The Model Portfolio of the Buffett-Munger screener has outperformed the market every year since inception in 2009.


Zhongyuan Union Cell & Gene Engineering Operating Margin % Related Terms

Thank you for viewing the detailed overview of Zhongyuan Union Cell & Gene Engineering's Operating Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.


Zhongyuan Union Cell & Gene Engineering Business Description

Traded in Other Exchanges
N/A
Address
45 East of Tianjin Airport Economic Zone nine, Tianjin, CHN, 300304
Zhongyuan Union Cell & Gene Engineering Corp Ltd is engaged in stem cell technology research, as well as detection and storage sources of stem cells in China. The company insists on the core strategy upon dual-core development of 'cell + gene' with the major businesses covering various cell storage businesses of newborns and adults; the preparation and storage of cord blood hematopoietic stem cells, umbilical cord mesenchymal stem cells, placental pluripotent stem cells, adipose-derived stem cells and immune cells; genetic testing services relating to children's genes.
Executives
Li De Fu Director
Wang Xue Jun senior management
Wang Yong Director
Li Hai Bin Director
He Wei senior management
Li Qiang senior management
Wu Ming Yuan Director
Wang Hui Director
Huang Jia Xue senior management
Cao Hai Feng Director
Han Yue E Director
Liu Yong Jun senior management
Cui Jing Xue Supervisors
Yang Guang Xing senior management
Meng Zhi Hong senior management

Zhongyuan Union Cell & Gene Engineering Headlines

No Headlines